For most medical practices, prior authorization still means a staff member on hold with a pharmacy benefit manager, faxing a form, and waiting days for an answer while a patient’s prescription sits unfilled. Electronic prior authorization (ePA) replaces that workflow with a standards-based electronic transaction embedded directly in the prescribing process — and starting in 2027, a large share of U.S. payers will be required to support it. For Arizona practices that have spent years hearing about interoperability mandates without a hard deadline attached, this one has a date on it.
What Electronic Prior Authorization Actually Replaces
Traditional prior authorization runs through phone calls, fax forms, and manual data entry, with no shared data format between the prescriber’s system and the payer’s system. Electronic prior authorization uses a standardized electronic transaction — built on the same medication-ordering data model as e-prescribing — so the prescriber’s system can submit a request and receive a structured, often automated, answer without a human re-keying anything. That structure is what makes the exchange auditable and fast instead of a black box that depends on whoever picks up the phone.
The NCPDP SCRIPT Standard Timeline
The transaction format itself comes from the National Council for Prescription Drug Programs (NCPDP), whose SCRIPT Standard governs electronic prescribing messages nationally. ePA capability was added to SCRIPT in stages, and the version a practice’s e-prescribing platform runs determines what it can actually do:
| NCPDP SCRIPT Version | What It Enabled | Regulatory Milestone |
|---|---|---|
| 2013071 | First version to include ePA transactions, with a standardized question-and-answer structure customized by patient and medication | Baseline ePA capability |
| 2017071 | Real-time ePA processing | CMS permitted this version for Medicare Part D plans’ ePA under a 2020 final rule (CMS-4189-F), with a compliance baseline of January 1, 2023 |
| 2023011 | Unifies ePA, real-time benefit checks, and formulary/benefit transactions into a single framework | Mandated by ONC rules under the 21st Century Cures Act, with a compliance date of January 1, 2028 for e-prescribing networks |
The practical implication: a practice’s EHR or e-prescribing vendor needs to be current on which SCRIPT version it runs, because the compliance dates above are not optional upgrades on the vendor’s roadmap — they are federally set.
The Federal Deadline That Changes the Calculus
Separately from the SCRIPT version timeline, the Centers for Medicare and Medicaid Services (CMS) finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F), which requires impacted payers — including Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan issuers on the federal exchanges — to support an adopted NCPDP SCRIPT version for electronic prior authorization on pharmacy-benefit drugs. Those payers must stand up a Prior Authorization API by January 1, 2027, so providers can submit requests and receive decisions electronically rather than by fax. CMS is also layering in an incentive: an Electronic Prior Authorization measure is being added to the Merit-Based Incentive Payment System (MIPS) and the Medicare Promoting Interoperability Program, optional for bonus points starting calendar year 2027 and mandatory for eligible hospitals and critical access hospitals beginning CY 2028.
In plain terms, a practice that treats ePA as a "someday" project is going to find the payer side of that transaction arriving on a fixed schedule whether the practice is ready or not.
What the Switch Actually Changes on the Ground
The gap between manual and electronic prior authorization is not marginal. Reported figures for ePA versus fax-and-phone processes include:
- Decisions in minutes to hours rather than days or weeks, with one report finding that roughly six in ten ePA requests received a determination in under two hours.
- One study found ePA cut the time between submitting a request and receiving a payer decision by 69%, and prospective ePA — initiated at the point of prescribing rather than after a claim rejection — got patients to their medication roughly 13 days faster than the retrospective path.
- Manual prior authorization requests are commonly estimated to cost $10–$25 each in administrative time, contributing to an estimated $23–$31 billion a year in U.S. prior authorization processing costs; automating the workflow has been associated with cost-per-transaction reductions and staff-time reductions in the 30–50% range for practices that fully implement it.
- CMS itself estimates the Interoperability and Prior Authorization Final Rule will produce at least $16 billion in savings over ten years, most of it accruing to providers rather than payers.
None of that requires a practice to build anything from scratch. The national e-prescribing networks that already route most prescriptions — Surescripts and CoverMyMeds among the most widely used — have built ePA modules that plug into existing EHR workflows, and the NCPDP SCRIPT standard is what lets a practice’s system, the pharmacy, and the payer all read the same transaction.
The Real Buyer Question: Network Capability, Not Just a Checkbox
The question most practices actually face is not "should we do ePA" — that decision is being made for them by the January 2027 payer deadline — it’s which piece of their existing technology stack needs to change to support it. For some practices that means confirming their EHR vendor is current on SCRIPT 2017071 or later. For others, particularly smaller practices on older e-prescribing modules, it means the EHR itself needs an upgrade or a bolt-on ePA connection before the payer side goes live. Getting that assessment right — who among the practice’s existing vendors already supports real-time ePA, and who doesn’t — is exactly the kind of standards literacy that gets lost between an EHR sales pitch and a compliance memo.
That is squarely the gap a neutral, standards-focused matching resource is built to close: connecting an Arizona practice to vendors who can be evaluated against the actual NCPDP version and CMS deadline requirements, rather than against a generic feature list. Medication ordering visibility only works when every party in the transaction — prescriber, pharmacy, and payer — is speaking the same standardized format, and getting there before 2027 is now a scheduling problem as much as a technology one.